GRAHAM PETER J
Insider CIK 1235635 · ATRS See Remarks · ADCT Chief Legal Officer · DCTH EVP; General Counsel
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ADCT ADC Therapeutics SA | A Award | 2026-06-30 | 2026-07-02 | 221,100 | — | $0 | 841,640 | SEC↗ |
| ADCT ADC Therapeutics SA | F Tax w/h | 2026-02-13 | 2026-02-18 | 33,294 | $3.99 | $132.8K | 620,540 | SEC↗ |
| ADCT ADC Therapeutics SA | A Award | 2026-02-13 | 2026-02-18 | 294,800 | $3.99 | $1.18M | 653,834 | SEC↗ |
| ADCT ADC Therapeutics SA | F Tax w/h | 2025-12-06 | 2025-12-09 | 49,508 | $3.29 | $162.9K | 359,034 | SEC↗ |
| ADCT ADC Therapeutics SA | A Award | 2025-02-13 | 2025-02-14 | 220,000 | $1.61 | $354.2K | 408,542 | SEC↗ |
| ADCT ADC Therapeutics SA | F Tax w/h | 2024-12-06 | 2024-12-09 | 41,458 | $3.13 | $129.8K | 188,542 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 170,227 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 212,900 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 163,963 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 254,165 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 125,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 177,453 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 217,725 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer | 2022-05-24 | 2022-05-26 | 202,139 | $5.60 | $1.13M | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer | 2022-05-24 | 2022-05-26 | 414,470 | $5.60 | $2.32M | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer | 2022-05-24 | 2022-05-26 | 124,234 | $5.60 | $695.7K | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2022-03-03 | 2022-03-04 | 13,635 | $3.80 | $51.8K | 616,609 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2022-03-03 | 2022-03-04 | 26,044 | — | $0 | 630,244 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2022-02-16 | 2022-02-18 | 13,299 | $3.66 | $48.7K | 604,200 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2022-02-16 | 2022-02-18 | 23,068 | — | $0 | 617,499 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2021-06-13 | 2021-06-14 | 14,790 | $4.45 | $65.8K | 594,431 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2021-06-11 | 2021-06-14 | 23,010 | $4.45 | $102.4K | 609,221 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2021-06-10 | 2021-06-14 | 163,963 | — | $0 | 163,963 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2021-06-10 | 2021-06-14 | 85,973 | $4.42 | $380.0K | 632,231 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2021-06-08 | 2021-06-10 | 15,996 | $4.39 | $70.2K | 546,258 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2021-03-01 | 2021-03-03 | 23,992 | $4.50 | $108.0K | 562,254 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2021-03-01 | 2021-03-03 | 45,829 | — | $0 | 586,246 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2021-02-18 | 2021-02-19 | 45,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2021-02-18 | 2021-02-19 | 45,000 | $1.12 | $50.4K | 585,417 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2021-02-18 | 2021-02-19 | 40,000 | $4.91 | $196.4K | 545,417 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2021-02-18 | 2021-02-19 | 5,000 | $5.05 | $25.3K | 540,417 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2021-02-17 | 2021-02-19 | 42,073 | $4.73 | $199.0K | 540,417 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2021-02-17 | 2021-02-19 | 80,365 | — | $0 | 582,490 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2020-06-13 | 2020-06-15 | 15,036 | $2.78 | $41.8K | 502,125 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2020-06-11 | 2020-06-15 | 254,165 | — | $0 | 254,165 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2020-06-11 | 2020-06-15 | 131,868 | $2.73 | $360.0K | 517,161 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2020-06-08 | 2020-06-09 | 16,261 | $3.13 | $50.9K | 385,293 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2020-06-07 | 2020-06-09 | 17,994 | $3.12 | $56.1K | 401,554 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2020-02-19 | 2020-02-21 | 29,947 | $3.53 | $105.7K | 419,548 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2020-02-19 | 2020-02-21 | 63,234 | — | $0 | 449,495 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2019-06-13 | 2019-06-14 | 170,227 | — | $0 | 170,227 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2019-06-13 | 2019-06-14 | 84,760 | $2.92 | $247.5K | 386,261 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2019-06-08 | 2019-06-11 | 11,678 | $2.81 | $32.8K | 301,501 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2019-06-07 | 2019-06-11 | 12,922 | $2.81 | $36.3K | 313,179 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2019-06-02 | 2019-06-04 | 15,421 | $2.79 | $43.0K | 326,101 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2019-02-20 | 2019-02-22 | 84,735 | — | $0 | 373,908 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2019-02-20 | 2019-02-22 | 32,386 | $3.20 | $103.6K | 341,522 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2018-06-08 | 2018-06-11 | 177,453 | — | $0 | 177,453 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2018-06-08 | 2018-06-11 | 91,667 | $2.70 | $247.5K | 289,173 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2018-06-07 | 2018-06-11 | 12,923 | $2.70 | $34.9K | 197,506 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2018-06-02 | 2018-06-05 | 15,422 | $2.69 | $41.5K | 210,429 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2017-06-07 | 2017-06-09 | 217,725 | — | $0 | 217,725 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2017-06-07 | 2017-06-09 | 101,434 | $2.66 | $269.8K | 225,851 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2017-06-02 | 2017-06-09 | 16,633 | $2.57 | $42.7K | 124,417 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2016-06-02 | 2016-06-06 | 257,900 | — | $0 | 257,900 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2016-06-02 | 2016-06-06 | 121,050 | $1.12 | $135.6K | 141,050 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | P Buy | 2016-03-21 | 2016-03-23 | 20,000 | $0.77 | $15.4K | 20,000 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2015-07-14 | 2015-07-16 | 125,000 | — | $0 | 125,000 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2015-07-14 | 2015-07-22 | 125,000 | — | $0 | 125,000 | SEC↗ |
| DCTH DELCATH SYSTEMS, INC. | A Award deriv | 2013-11-14 | 2013-11-18 | 152,755 | — | $0 | 152,755 | SEC↗ |
| DCTH DELCATH SYSTEMS INC | A Award deriv | 2013-03-11 | 2013-03-13 | 40,000 | — | $0 | 40,000 | SEC↗ |
| DCTH DELCATH SYSTEMS INC | A Award deriv | 2012-02-28 | 2012-03-01 | 40,000 | — | $0 | 0 | SEC↗ |
| DCTH DELCATH SYSTEMS INC | A Award | 2012-02-28 | 2012-03-01 | 9,000 | — | $0 | 15,000 | SEC↗ |